Asuragen Scientific Publications

Asuragen has researched and published extensively in genetics, oncology, molecular diagnostics, and technology advancements for over 15 years. These publications, posters, and white papers cover various disease areas and their related genes including fragile X (FMR1), spinal muscular atrophy (SMN1/SMN2), cystic fibrosis (CFTR), and chronic myeloid leukemia (BCR-ABL1). They show the power of detecting and interpreting molecular alterations using AmplideX and QuantideX technologies as well as the value of Molecular Quality Controls and companion diagnostics collaborations to deliver new insights and advance precision medicine. Simply search by term, filter by category, or use both to find your area of interest.

We’re driven to provide people with better answers, so we ensure our products are supported by reliable data and backed by rigorous science. Dive into these publications to learn more.

Verification of an Amplification Based Nanopore Sequencing Assay and Software to Genotype Complex, Clinically-Relevant Variants in 11 Hard-to-Decipher Genes with High Carrier Frequencies
Connor A. Parker, Jonathan Turner, Brennan Greenlee, Juliette A. Baker, Walairat L. Wolf, Christopher J. Fraher, Monica Roberts, Theodore Markulin, Eduardo Priego, Mahesh Yarasi, Mia K. Mihailovic, Bryan J. Killinger, Brian C. Haynes, Bradley Hall, and Ashima Sharma
Resolving Complex Genotypes in Residual Clinical Samples with Long Range-PCR and Nanopore Sequencing Assay
Cody Edwards, Bryan Killinger, Andrew Laurie, Lisa Hsu, Anne-Sophie Lebre, Tony Yammine, Chandler Ho, Tsoyu Chiang, Ilona Volkova, Monica Roberts, Theodore Markulin, Mia Mihailovic, Eduardo Priego, Brian C. Haynes, Bradley Hall
Back To
Top